BillionToOne, Inc. (BLLN)의 가격은 얼마입니까?

BillionToOne, Inc. (BLLN)의 가격은 $99.89입니다.

BillionToOne, Inc. (BLLN)의 시가 총액은 무엇입니까?

BillionToOne, Inc. (BLLN)의 시가 총액은 $4.59B입니다.

BillionToOne, Inc. (BLLN) 배당수익률

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

연도	배당 수익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당 수익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	배당 수익률	국가
Thermo Fisher Scientific Inc. TMO.US	0.31%	US
Danaher Corporation DHR.US	0.71%	US
WuXi AppTec Co., Ltd. 603259.SS	0.00%	CN
Natera, Inc. NTRA.US	0.00%	US
Agilent Technologies, Inc. A.US	0.68%	US

회사

배당 수익률

국가